Xiidra® is now accessible through the innovative MyRx Care™ platform, as part of the Bausch + Lomb Patient Support Program.  Eligible patients can now benefit from financial assistance to make their treatment more affordable and accessible.

Blair Rutledge, President of  MyRx Care™, stated, "We are delighted to welcome Bausch + Lomb as our latest Partner on MyRx.care.   Our mission is to provide innovative solutions to our partners and  improve patient access and support for essential medications.”

Key highlights of this exciting addition include:

1. Financial Assistance for Canadian Xiidra® Patients: Patients in Canada now have access to financial assistance through the Bausch + Lomb Patient Support Program on  MyRx Care™.
2. Xiidra® Financial Assistance Card: Healthcare professionals can now provide eligible patients with the Xiidra® Financial Assistance Card, which can be used immediately.
3. Innovative Patient Financial Assistance Platform:  MyRx Care™ is widely recognized as the most innovative patient financial assistance platform in Canada. It offers a user-friendly interface and streamlined processes to help patients access the support they need with ease.

This collaboration between Bausch + Lomb and  MyRx Care™ underscores our joint commitment to improving the lives of Canadians. By making Xiidra® more accessible through financial assistance, we aim to enhance the quality of life and ensure patients have access to effective treatment options.

For more information about the Bausch + Lomb Patient Support Program and  MyRx Care™, please visit https://myrx.care/bausch-lomb/ .

About MyRx Care

MyRx Care™ is a leading patient financial assistance platform in Canada, dedicated to connecting patients with access to essential medications and support. Our innovative solutions empower patients and healthcare providers to take control of their healthcare journey. For more information, visit https://about.myrx.care . Or contact us directly at [email protected] or 647-598-1871.